Skip to main content
$65.87 $0.06 (0.1%)

04:00 PM EDT on 10/22/21

MetLife, Inc. (NYSE:MET)

CAPS Rating: 2 out of 5

The Company is a provider of insurance and other financial services with operations throughout the United States and the regions of Latin America, Europe, and Asia Pacific.

Current Price $65.87 Mkt Cap $56.4B
Open $66.06 P/E Ratio 13.31
Prev. Close $65.87 Div. (Yield) $1.92 (2.9%)
Daily Range $65.30 - $66.41 Volume 3,902,654
52-Wk Range $35.90 - $67.68 Avg. Daily Vol. 4,507,962

Caps

How do you think NYSE:MET will perform against the market?

Add Stock to CAPS Watchlist

All Players

741 Outperform
84 Underperform
 

All-Star Players

115 Outperform
9 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:MET Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

CoreAndExplore (< 20)
Submitted May 07, 2012

Hard to ignore this ridiculous valuation at 6x 2013 earnings. MET is a strong brand with a much improved balance sheet.

marcad28 (86.01)
Submitted March 13, 2008

i believe that because we are going into a recession, more people will be losing their jobs and will not be able to afford insurance...the average monthly payment for a single person is about $250, for a senior citizen $400+ and what about for a… More

Recent Community Commentary

Read the most recent pitches from players about MET.

Recs

0
Member Avatar XMFFlygal (99.49) Submitted: 8/23/2021 9:43:28 PM : Outperform Start Price: $58.02 NYSE:MET Score: -5.09

Second Quarter Results Summary
• Net income of $3.4 billion, or $3.83 per share, compared to net income of $68 million, or $0.07 per share, in the second quarter of 2020.
• Adjusted earnings of $2.1 billion, or $2.37 per share, compared to adjusted earnings of $758 million, or $0.83 per share, in the second quarter of 2020.
• Book value of $75.86 per share, down 4 percent from $78.65 per share at June 30, 2020.
• Book value, excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA), of $56.38 per share, up 8 percent from $52.27 per
share at June 30, 2020.
• Return on equity (ROE) of 21.2 percent.
• Adjusted ROE, excluding AOCI other than FCTA, of 17.5 percent.
• f $6.5 billion at June 30, 2021, which
the target cash buffer of $3.0 - $4.0 billion.

Recs

0
Member Avatar drewpf (28.89) Submitted: 5/2/2021 11:10:14 AM : Outperform Start Price: $62.97 NYSE:MET Score: -3.21

Coming inflation is going to allow pricing power on premiums . Also inflation means higher interest rates , which improve net interest margins for financials

Recs

0
Member Avatar Saltygran (57.20) Submitted: 4/25/2021 8:49:11 AM : Outperform Start Price: $61.63 NYSE:MET Score: -1.44

Inflation

Leaderboard

Find the members with the highest scoring picks in MET.

Score Leader

Richthofen80

Richthofen80 (83.13) Score: +237.40

The Score Leader is the player with the highest score across all their picks in MET.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Richthofen80 83.13 12/26/2008 Underperform 1Y $22.67 +191.19% +428.59% +237.40 1 Comment
OhMyO9 58.41 1/29/2009 Underperform 3W $21.71 +204.08% +435.44% +231.36 0 Comment
wineag < 20 10/7/2008 Underperform 3Y $30.25 +118.20% +335.27% +217.07 0 Comment
Isis3 22.32 11/7/2008 Underperform 3M $22.57 +192.44% +407.36% +214.92 0 Comment
loudoungroup < 20 12/8/2008 Underperform NS $21.98 +200.35% +414.67% +214.33 0 Comment
midas784 < 20 1/14/2009 Underperform 1Y $19.96 +230.72% +438.71% +207.99 0 Comment
GenericMike 23.15 4/30/2009 Underperform 3M $20.78 +217.63% +422.20% +204.58 0 Comment
DoctorMAD 28.42 5/6/2009 Underperform 5Y $22.04 +199.50% +397.04% +197.54 0 Comment
Buckaneer < 20 5/19/2009 Underperform NS $21.48 +207.30% +402.17% +194.87 0 Comment
marketjunkie08 < 20 10/23/2008 Underperform 3Y $20.60 +220.42% +413.84% +193.42 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MET.